PRTA

8.1602.86%
TB

Tran B. Nguyen

Chief Financial Officer

Mr. Tran B. Nguyen, M.B.A. served as Chief Strategy Officer of Prothena Corporation plc since October 1, 2021 until April 10, 2026. He serves as Independent Director at Rain Oncology Inc. (formerly known as Rain Therapeutics Inc.) since April 2018. He has been Chief Financial Officer of Prothena Corporation plc since March 2013 and also served as its COO since June 2018 until September 2021 and served as its Principal Accounting Officer. Mr. Nguyen has finance experience in the healthcare, banking and private equity industries. Prior to joining Prothena, he served as the Chief Financial Officer from April 12, 2010 to 2013, Senior Vice President from February 10, 2011 t o 2013, Vice President from 2010 to 2011 and served as its Principal Accounting Officer until 2013 of Somaxon Pharmaceuticals, Inc. He served as Vice President of Corporate and Investment Banking at West Coast of Citigroup Inc. since May 24, 2007. He served as a Vice President at Pernix Sleep, Inc. from April 12, 2010 to February 10, 2011 and also served as its Chief Financial Officer since April 12, 2010, Senior Vice President since February 10, 2011 and Principal Accounting Officer. He served as Vice President of Finance and Principal Accounting Officer at Metabasis Therapeutics, Inc. He served as a Treasurer and Corporate Secretary of Metabasis Therapeutics Inc. He served as the Chief Financial Officer and Vice President at Metabasis Therapeutics Inc. from March 2009 to 2010 and was primarily responsible for managing the financial operations. From May 2007 to January 2009, he was a part of the Healthcare Investment Banking group of Citi Global Markets Inc. as a Vice President, where he specialized in working with large-to-small capitalization biotechnology and specialty pharmaceutical companies. Prior to joining Citigroup Global Markets, he served as a Vice President of the Healthcare Investment Banking group at Lehman Brothers Inc., from January 2006 to April 2007 and as an Associate from July 2004 to December 2005. Prior to joining Lehman Brothers, he held various analytical financial positions at private equity and investment banking companies including CP Group, Waterton Management LLC, Merrill Lynch & Co. and Merrill Lynch International. He had been an Independent Director of Sierra Oncology, Inc. since March 18, 2016 until November 22, 2019. Mr. Nguyen holds B.A. degree in Economics and Psychology from Claremont McKenna College in 1995 and an M.B.A. degree from The Anderson School of Management at University of California, Los Angeles.

公司職務